John P. Mulhall, MD, presented “Testosterone and PSA—A Critical Relationship” during the Jackson Hole Seminars on January 30, 2019 in Jackson Hole, Wyoming.
How to cite: Mulhall, John P. “Testosterone and PSA—A Critical Relationship” January 30, 2019. Accessed [date today]. https://grandroundsinurology.com/testosterone-and-psa-a-critical-relationship/
Testosterone and PSA—A Critical Relationship – Summary:
John P. Mulhall, MD, discusses the results and implications of a study evaluating the relationship between testosterone and PSA levels in men with prostate cancer. He suggests that these findings indicate that in men with documented prostate cancer, the presence of a pretreatment PSA value below 2 should raise questions about a patient’s testosterone level.
About the Ralph E. Hopkins Urology Seminar
The Ralph E. Hopkins Urology Seminar, or Jackson Hole Seminars (JHS), is a multi-day conference that focuses on patient safety and cutting-edge updates in the assessment, diagnosis, and treatment of urologic conditions. The topics discussed include urologic cancers, stone disease, urologic reconstruction, female urology, infertility, emerging surgical techniques, and general urology. In addition to didactic expert lectures, this conference features unique interactive critique panel. Dr. Mulhall presented this lecture during the 39th Annual JHS. Please visit this page in order to register for future JHS meetings.
ABOUT THE AUTHOR
John P. Mulhall, MD, is the director of the Male Sexual and Reproductive Medicine Program and the director of the Sexual Medicine Research Laboratory at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City. Dr. Mulhall holds an adjunct position as Professor of Urology in the Department of Urology at Weill Cornell Medical College. He earned his medical degree from University College Dublin in Ireland and completed his urology residency training at University of Connecticut Health Center and his sexual/reproductive medicine & surgery fellowship training at Boston University Medical Center. Dr. Mulhall has spent more than a decade studying radical prostatectomy associated with sexual dysfunctions and Peyronie’s Disease in laboratory and in clinical studies. His basic research interests include defining the pathobiology of Peyronie’s disease fibroblasts and erectile function preservation in cavernous nerve injury models.
Dr. Mullhall is a board-certified urologist and a microsurgeon who specializes in sexual and reproductive medicine and surgery. As a microsurgeon, he performs delicate procedures using operating microscopes and miniaturized precision instruments on the very small structures in the genitourinary tract. As part of Memorial Sloan Kettering Cancer Center’s Survivorship Initiative, Dr. Mulhall and his team have established a Male Sexual and Reproductive Medicine Program, which is devoted entirely to the care of men who have suffered sexual difficulties or fertility problems as a result of their cancer or cancer treatment. He directs the sexual and reproductive medicine team, which includes a nurse practitioner, a nurse, and a psychologist.
